|
Market Closed -
Nasdaq
16:00:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 17.15 USD | -3.43% |
|
-23.95% | - |
| 09-20 | Latigo Biotherapeutics, Inc.(NasdaqGS:LTGO) added to S&P TMI Index | CI |
| 09-03 | Latigo Biotherapeutics Q2 Net Loss Narrows | MT |
Evolution of the Average Target: Latigo Biotherapeutics, Inc.
Evolution of the Target Price: Latigo Biotherapeutics, Inc.
Changes in Analyst Recommendations: Latigo Biotherapeutics, Inc.
232fcc495410bbd24cb.kkDuDCNgGKErNAK8JDgJALDUXVToDl17F4yN_t8l_2k.-DnadhQ1IflHAVaMU1UwSdznagfZOmRNcc_4ieduqlqrbblNbihBjAZcbQ~2507ba2a826b2fcc9b802ab17524addd
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +204.66% | |||
| +20.9% | |||||
| +2.8% | |||||
| +23.88% | |||||
| +19.94% | |||||
| +50.95% | |||||
| -5.99% | |||||
| -19.36% | |||||
| -6.61% | |||||
| +38.36% | |||||
| Average | +32.95% | |||||
| Weighted average by Cap. | +17.76% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
17.15USD
Average target price
52.25USD
Spread / Average Target
+204.66%
High Price Target
73.00USD
Spread / Highest target
+325.66%
Low Price Target
36.00USD
Spread / Lowest Target
+109.91%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- LTGO Stock
- Consensus Latigo Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
